Medicina
Departamento
McMaster University
Hamilton, CanadáPublicaciones en colaboración con investigadores/as de McMaster University (45)
2024
2023
-
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients with Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)
Journal of Clinical Oncology, Vol. 41, Núm. 1, pp. 43-53
-
EAACI guidelines on the diagnosis of IgE-mediated food allergy
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 12, pp. 3057-3076
-
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1605-1615
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Coronary lithotripsy for the treatment of underexpanded stents: the international & multicentre CRUNCH registry
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 7, pp. 574-581
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
-
Protocol for a systematic review of the diagnostic test accuracy of tests for IgE-mediated food allergy
Pediatric Allergy and Immunology, Vol. 33, Núm. 1
-
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 17, Núm. 16, pp. 1330-1339
-
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
The Lancet, Vol. 399, Núm. 10333, pp. 1383-1390
2021
-
Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment-Elevation Myocardial Infarction: Insights From the COMPLETE Trial
Circulation: Cardiovascular Interventions, Vol. 14, Núm. 8, pp. E010458
-
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials
Journal of the American College of Cardiology, Vol. 77, Núm. 19, pp. 2366-2377
-
Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study
Journal of Psychosomatic Research, Vol. 140
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964
-
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial
Trials, Vol. 22, Núm. 1
2019
-
2019 ARIA Care pathways for allergen immunotherapy
Allergologie, Vol. 42, Núm. 9, pp. 404-425
-
2019 ARIA Care pathways for allergen immunotherapy
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 11, pp. 2087-2102
-
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
The Lancet Oncology, Vol. 20, Núm. 10, pp. e566-e581
-
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Nature Communications, Vol. 10, Núm. 1
-
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document
Circulation, Vol. 140, Núm. 5, pp. 420-433